Objective: To compare nationwide outcomes of tension-free vaginal mesh surgery and laparoscopic sacrocolpopexy for the treatment of pelvic organ prolapse in Japan. Methods: Using the Diagnosis Procedure Combination database, we collected data on female patients who underwent tension-free vaginal mesh surgery or laparoscopic sacrocolpopexy for pelvic organ prolapse from April 2014 to March 2015. We compared the proportion of perioperative adverse events, duration of anesthesia, total costs and postoperative length of stay between the groups. Univariate and multivariate analyses were carried out for age, comorbidity, mesh volume, additional concomitant surgery and hospital volume. Results: We identified 3023 patients, including 2388 who underwent tension-free vaginal mesh surgery, and 635 who underwent laparoscopic sacrocolpopexy. The median age at the time of surgery was significantly higher in the tension-free vaginal mesh group (71 vs 66 years; P < 0.001). The tension-free vaginal mesh group had a higher proportion of all adverse events (7.1% vs 1.8%; P < 0.001) and a higher proportion of genitourinary complications (5.7% vs 1.1%; P < 0.001). The median duration of anesthesia was shorter in the tension-free vaginal mesh group (150 vs 286 min; P < 0.001). The total cost was significantly lower in the tension-free vaginal mesh group. Conclusions: Both procedures offer favorable results for surgical treatment of pelvic organ prolapse. Overall, the tension-free vaginal mesh procedure seems to represent a good option for high-risk women, such as elderly patients, whereas laparoscopic sacrocolpopexy is useful for younger patients with a higher level of sexual activity.
Introduction
Female POP, a pelvic floor disorder, is defined as herniation of pelvic organs into or through the vagina or anus. The etiologies of POP include both genetic and environmental factors. Distinctive fascial damage caused by vaginal childbirth and vaginal atrophy by aging are the main causes of POP. 1, 2 Because most cases of POP cause significant symptoms related to daily activities, sexual function and exercise, 3, 4 affected patients experience a deteriorated quality of life. 5 Symptomatic POP can be managed with conservative or surgical therapy. Surgical therapy is carried out for patients with POP who have undergone failed conservative therapy or have declined conservative therapy. One study showed that the incidence of POP was positively associated with aging, and the lifetime risk of these surgeries until the age of 85 years was reportedly 20.5%. 6 Numerous surgical techniques for POP repair are currently available, including vaginal and abdominal approaches. TVM surgery involves implantation of a synthetic mesh (polypropylene mesh) in the vesicovaginal and rectovaginal dissection spaces. Since the introduction of GYNEMESH PS (Ethicon, Somerville, NJ, USA) in 2005, TVM surgery has become widespread throughout Japan because of its lower recurrence rates compared with conventional treatments. [7] [8] [9] Previous reports have mentioned that the recurrence rate associated with conventional treatments and TVM surgery are approximately 20% and 8%, respectively. [7] [8] [9] [10] [11] However, the United States Food and Drug Administration published a safety alert regarding TVM surgery in 2008 and 2011 because of a significant increase in the number of reported adverse events. 12 The most common adverse events associated with TVM were mesh erosion, pain during intercourse, infection, urinary problems, bleeding and organ perforation.
LSC has recently been examined as an alternative to TVM. In LSC, synthetic mesh is placed intra-abdominally to support the vaginal wall and suspend the vaginal apex to the sacral anterior longitudinal ligament with laparoscopic techniques. LSC was approved for inclusion in the Japanese public insurance system in 2014, and the number of hospitals carrying out LSC is rapidly increasing. However, data regarding perioperative outcomes of TVM and LSC in Japan since publication of the United States Food and Drug Administration alert are lacking. In the present study, we examined the clinical characteristics and outcomes of these two surgeries to determine the surgical outcomes of POP operations using a Japanese national inpatient database.
Methods

Data source
We used the DPC database, a Japanese national inpatient database, to carry out the present study. The DPC database was settled based on the Japanese administrative claim system named Diagnosis Procedure Combination, for the purpose of enhancing clinical, epidemiological and medical economics analysis. The DPC Research Institute (http://dpcri. or.jp/) has made a contract with each hospital for research use and confidentiality of the DPC data, and the data from agreed hospitals (≥80% of all DPC system participant hospitals) were accumulated as the DPC database. Approximately 1000 hospitals participated in this database in 2014. 13 The database includes discharge abstract and administrative claims data on acute-care inpatients, including age; sex; main diagnosis, comorbidities at admission and complications emerging after admission coded by the International Statistical Classification of Diseases and Related Health Problems 10th Revision; and surgical procedures coded by the Japanese original codes.
We included female inpatients with the main diagnosis of female genital prolapse (N81.x) who underwent TVM (Kcode: K802-21) or LSC (K802-6) from April 2014 to March 2015. Patient background information included age, comorbidities, consumed mesh volume, additional concomitant surgeries and hospital volume. Comorbidities were converted to the Charlson Comorbidity Index.
14 Consumed mesh volume was a total of pre-offcut mesh sheet volume. Due to the database limitation, information of accurate offcut mesh size was not available. Hospital volume was defined as the average annual number of TVM and LSC procedures carried out in each hospital. Concomitant surgeries are listed in Table S2 .
End-points
Four perioperative outcomes were compared between the TVM and LSC groups: (i) overall adverse events including mortality; (ii) duration of anesthesia; (iii) total cost (1 USD was assumed to be equivalent to 100 Japanese yen); and (iv) postoperative length of stay. Definitions of adverse events are listed in Table S1 .
Statistical analyses
The patients' baseline characteristics and perioperative outcomes were summarized for both the TVM and LSC groups. The v 2 -test and Mann-Whitney U-test were used for univariable comparisons, as appropriate. We carried out a multivariable logistic regression analysis for overall adverse events and multivariable linear regression analyses for the duration of anesthesia, total costs and postoperative length of stay. To adjust for within-hospital clustering, we fitted each regression model with a general equation estimation. 15 All statistical analyses were carried out using SPSS version 22.0 (IBM, Armonk, NY, USA). The threshold for significance was P < 0.05.
Ethics
Because the data were thoroughly de-identified and the current study was designed as a secondary analysis of anonymous data, informed consent was not required. The institutional review board and ethics committee of The University of Tokyo approved the current study (approval number, 3501).
Results
We identified a total of 3013 eligible patients, including 2388 who underwent TVM surgery and 625 who underwent LSC, from 196 hospitals. Table 1 shows the details of the baseline patient characteristics including age, Charlson Comorbidity Index, mesh volume, hospital volume and perioperative adverse events. In the univariate comparisons, LSC was more likely than TVM surgery to be carried out in younger patients (median 66 vs 71 years, respectively; P < 0.001) and patients with fewer comorbidities (P = 0.025) at high-volume hospitals (median 74 vs 30 patients per year, respectively; P < 0.001). LSC used a significantly larger mesh size than TVM (median 600 vs 300 cm 2 , respectively; P < 0.001). The incidence of overall perioperative adverse events in LSC was significantly lower than that in TVM (1.9% vs 7.1%, respectively; P < 0.001). The overall proportion of genitourinary events was significantly lower in the LSC than TVM group (1.1% vs 5.7%, respectively; P < 0.001), as was the proportion of urethral stenosis/retention/dysuria (0.3% vs 2.0%, respectively; P = 0.004) and vaginitis/vulvitis (0.3% vs 2.6%, respectively; P < 0.001). The LSC and TVM groups showed no significant difference in the proportions of total non-genitourinary events (0.8% vs 1.4%, respectively; P = 0.219) or blood transfusion (0.2% vs 0.5%, respectively; P = 0.245). LSC was also associated with a significantly longer duration of anesthesia and higher total cost than TVM (median 286 vs 150 min, respectively; P < 0.001; median 8414 vs 6952 USD, respectively; P < 0.001). Table 2 shows the results of the multivariable regression analyses for perioperative outcomes. LSC was significantly associated with a lower probability of adverse events (odds ratio 0.40; 95% confidence interval 0.19-0.83). The anesthesia duration was 126 min longer with LSC than TVM.
Discussion
The use of synthetic mesh in the transvaginal approach is controversial. The recurrence rate, which was necessary for repeated surgery, associated with native-tissue repair is as high as 30%, especially for patients with anterior compartment defects; 7-9 thus, TVM quickly gained popularity because of its low recurrence rate. However, because of the high frequency of mesh-related adverse events, 16 the United States Food and Drug Administration issued statements about the safety of TVM and finally reclassified TVM as a highrisk device in prolapse repair. A previous multicenter randomized controlled trial in the UK (PROSPECT study) comparing TVM with traditional transvaginal repair showed no significant difference in outcomes including quality of life, and more than one in 10 women who underwent TVM surgery developed a mesh-related complication. 17 LSC has a durability success rate of 93-99%. According to another Cochrane review, abdominal sacrocolpopexy showed better outcomes, including a lower recurrence rate and less dyspareunia, than vaginal sacrospinous colpopexy. 18 LSC has technical difficulties associated with dissection of the bladder away from the anterior vagina along the vesicovaginal septum, mesh positioning in a tension-free manner and Data are presented as n (%), median (interquartile range) or mean (standard deviation). †The number of events was two or less; respiratory complications (n = 2, P = 0.30) and wound disruption (n = 1, P = 0.60). ‡The number of events was two or less; salpingo-oophoritis (n = 1, P = 0.05) and female pelvic inflammation (n = 1, P = 0.60).
suturing of the peritoneal reflection over the graft. 19 To our knowledge, the present study is the first to directly compare perioperative complications between LSC and TVM based on a Japanese multicenter dataset.
In the present study, TVM was associated with significantly higher proportions of genitourinary adverse events, especially voiding dysfunction and vaginitis. However, TVM showed favorable results with respect to the total cost and length of stay despite its performance by low-volume hospitals. Previous studies have shown that the blood transfusion rate during TVM surgery was between 0 and 2.3%. [20] [21] [22] These data show that the blood transfusion rate during TVM surgery in Japan tends to be low. With regard to vaginitis, the TVM group might have included patients prophylactically using estradiol vaginal tablets for mesh erosion rather than those with clinical vaginitis.
With respect to the duration of anesthesia and total cost, our results suggest that TVM surgery is less invasive, requires a shorter operation time and has a lower cost than LSC. The proportion of adverse events was higher in the TVM group; however, considering the lower cost burden in the TVM group, they were likely to be minor adverse events. Several previous studies on TVM carried out in high-volume hospitals showed significant improvement in terms of voiding function and sexual function after the surgery. 11, [23] [24] [25] These findings suggest that the performance of TVM surgery by experienced surgeons in high-volume centers could achieve lower complication rates.
The present study had several limitations. This was a retrospective database study, and unobserved confounders could have biased the results. Owing to the nature of administrative claims databases, underestimation or overestimation of comorbidities and adverse events could also have occurred. Detailed information about the surgery, including the need for mesh removal because of mesh erosion and dyspareunia, was not available. As was described previously, an actual offcut mesh size was unable to be measured in the present study. Despite the inaccuracy, we used the mesh data because it is useful to identify the number of mesh sheets consumed.
Surgical invasiveness for single-sheet mesh users and multiple-sheets ones could be different, and we recognized the necessity to adjust the background difference as much as possible. The study was carried out in the Japanese clinical setting, limiting the generalizability of the results so that DPC data is possible to evaluate surgical outcomes of these procedures, but not the efficacy of two operations. Despite these limitations, we believe that the current large-scale analysis has a significant impact on the future of clinical practice in women with POP.
In conclusion, both TVM surgery and LSC showed favorable results for POP. LSC has high safety in terms of urogenital adverse events involving voiding dysfunction and vaginal wall-related complications. Overall, TVM could be useful for high-risk women, such as elderly patients, whereas LSC would be useful for younger patients with a higher level of sexual activity. These results will help to make appropriate choices regarding these surgical options for POP. 
